Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04385251 · ClinicalTrials.gov registry record
International SARS-CoV-2 (COVID-19) Infection Observational Study
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 11,973
- Enrollment target
NCT04385251 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 11,973 participants.
The verdict
NCT04385251 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 11,973 participants
- Enrollment target
Study Summary
The general aim of this study is to estimate the rate of disease progression for adults testing positive for SARS-CoV-2. The primary endpoint for this study and the basis for sample size is hospitalization or death during the 28 day follow-up period. In some locations special facilities are being built/utilized for quarantine/public health reasons for those who are SARS-CoV-2 positive. Hospitalization is defined as a stay for at least 18 hours, irrespective of reason, at a hospital or one of these special facilities after study enrollment. Secondary outcomes include participant-reported health status and change in severity of dyspnoea.
Interventions
- OTHER Data Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,973 participants |
| Start Date | 2020-06-18 |
| Est. Completion | 2022-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04385251
The ClinicalTrials.gov registry entry for NCT04385251 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11,973 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Data Collection is the first listed.
NCT04385251 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04385251 about?
NCT04385251 is a clinical study titled "International SARS-CoV-2 (COVID-19) Infection Observational Study". The general aim of this study is to estimate the rate of disease progression for adults testing positive for SARS-CoV-2. The primary endpoint for this study and the basis for sample size is hospitalization or death during the 28 day follow-up period. In some locations special facilities are being bu...
What is the current status of trial NCT04385251?
This trial is currently completed. The enrollment target is 11,973 participants. The study started on 2020-06-18. Estimated completion is 2022-01-31.
What interventions are being tested in trial NCT04385251?
The interventions under investigation include: Data Collection (OTHER).
Who is sponsoring clinical trial NCT04385251?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.